P26663 (POLG_HCVBK) Hepatitis C virus genotype 1b (isolate BK) (HCV)

Genome polyprotein UniProtKBProtein AtlasInterProInteractive Modelling

3010 aa; Sequence (Fasta)

Available Structures

Envelope glycoprotein E2 384-746; PRO_0000037533

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the b… Heteromer
412-423
100GOL;CL;
Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the b… Heteromer
412-423
100NA;K;
Structure of the HCV1-C1 Antibody-Antigen Complex Heteromer
412-423
100ACT;CA;
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8rjj.1.Bmonomer0.68384-746
73.55
7t6x.1.Amonomer0.67420-717
NAG;79.83

Protease NS2 810-1026; PRO_0000037535

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.33PW1;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.331LH;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.33DJL;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.334VA;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.334VA;
Full-length HCV NS3-4A protease-helicase in complex with a macrocyclic protease inhibitor.homo-2-mer1013-1687
33.33ZN;F9K;

Serine protease/helicase NS3 1027-1657; PRO_0000037536

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A Heteromer
1029-1689
97.74ZN;
STRUCTURE OF HCV PROTEASE (BK STRAIN) Heteromer
1029-1689
97.75ZN;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.33PW1;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.331LH;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.33DJL;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.334VA;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.334VA;
Full-length HCV NS3-4A protease-helicase in complex with a macrocyclic protease inhibitor.homo-2-mer1013-1687
33.33ZN;F9K;
CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUShomo-2-mer1029-1693
81.25ZN;PO4;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
99.36SO4;10L;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
99.36SO4;20L;
Structure of hepatitis C virus (HCV) full-length NS3 complex with small-molecule ligand 5-bromo-1-m…homo-2-mer1029-1657
99.36R2N;
Structure of hepatitis C virus (HCV) full-length NS3 complex with small-molecule ligand 3-aminobenz…homo-2-mer1029-1657
99.36UP8;
Structure of hepatitis C virus (HCV) full-length NS3 complex with small-molecule ligand 2-(1-methyl…homo-2-mer1029-1657
99.363VY;
The structure of HCV NS3 helicase (Heli-80) bound with inhibitor ITMN-3479homo-2-mer1212-1656
96.39I79;MG;CL;
CRYSTAL STRUCTURE OF RNA HELICASE FROM GENOTYPE 1B HEPATITIS C VIRUS: MECHANISM OF UNWINDING DUPLEX…homo-2-mer1216-1650
96.32
X-ray crystal structure of NS3 Helicase from HCV with a bound fragment inhibitor at 2.08 A resoluti…monomer1212-1656
96.63NA;CL;3VY;
HEPATITIS C VIRUS NS3 PROTEINASEmonomer1028-1210
97.81ZN;
THE SOLUTION NMR STRUCTURE OF THE N-TERMINAL PROTEASE DOMAIN OF THE HEPATITIS C VIRUS (HCV) NS3-PRO…monomer1048-1207
96.88ZN;

Non-structural protein 4A 1658-1711; PRO_0000037537

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A Heteromer
1029-1689
97.74ZN;
STRUCTURE OF HCV PROTEASE (BK STRAIN) Heteromer
1029-1689
97.75ZN;
Crystal structure of HCV NS3/4A protease complexed with inhibitor Heteromer
Q0ZNA6;
1678-1689
100ZN;1RR;SO4;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.33PW1;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.331LH;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.33DJL;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.334VA;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
33.334VA;
Full-length HCV NS3-4A protease-helicase in complex with a macrocyclic protease inhibitor.homo-2-mer1013-1687
33.33ZN;F9K;
CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUShomo-2-mer1029-1693
81.25ZN;PO4;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
99.36SO4;10L;
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
99.36SO4;20L;

Non-structural protein 5A 1973-2419; PRO_0000037539

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus … Heteromer
P06241;
2321-2328
100GOL;CL;NA;

RNA-directed RNA polymerase 2420-3010; PRO_0000037540

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASEhomo-2-mer2422-2985
99.46
Hepatitis C virus polymerase NS5B (BK) with amide bioisostere thumb site inhibitorhomo-2-mer2421-2981
100.0HJZ;GOL;
Hepatitis C Virus RNA Polymerase in Complex with GTP and Manganesehomo-2-mer2420-2950
100GTP;MN;
Hepatitis C Virus RNA polymerase in complex with UTP and manganesehomo-2-mer2420-2950
100UTP; 10×MN;
Identification of Novel Allosteric Inhibitors of Hepatitis C Virus NS5B Polymerase Thumb Domain (Si…homo-2-mer2420-2950
100QQ3;
CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUShomo-2-mer2420-2950
99.62
Structure of hepatitis C virus NS5B polymerase in a new crystal formmonomer2420-2985
99.82ACY;GOL;
NS5b in complex with lactam-thiophene carboxylic acidsmonomer2422-2986
98.9333J;
HCV NS5B GT1B N316 with GSK5852Amonomer2420-2983
99.461PV;
HCV NS5B GT1B N316Y with CMPD 32monomer2420-2982
99.27690;
Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitormonomer2420-2982
99.82153;
HCV NS5B 1b N316 bound to Compound 18monomer2420-2982
99.27K4S;
HCV NS5B GT1B N316Y with CMPD 4monomer2420-2982
99.271C0;
HCV NS5B GT1B N316Y with GSK5852monomer2420-2982
99.271PV;
3-heterocyclyl quinolone bound to HCV NS5Bmonomer2420-2982
99.82KLI;
Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.monomer2420-2982
99.29NH1;
Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitormonomer2420-2982
99.82154;
Crystal Structure of HCV NS5B RNA polymerase in complex with PF868554monomer2420-2981
99.11AG0;AG6;BME;
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with small mole…monomer2421-2982
100.0ZN;
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2982
100.0NI;SX4;
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with small mole…monomer2421-2982
100.0SX2;
Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridinone inhibi…monomer2420-2981
99.82YAK;
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
99.82N35;
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2982
100.0SX6;
Hepatitis C virus polymerase NS5B with saccharin inhibitor 1monomer2421-2982
100.0H5U;
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223monomer2420-2981
99.64698;
HCV NS5B allosteric inhibitor complexmonomer2422-2983
99.46VRX;
Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)monomer2420-2981
98.74SO4;5X;
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
99.823MS;
Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5ee)monomer2420-2981
98.74SO4;5EE;
Crystal structure of HCV NS5B polymerase with a novel Pyridazinone inhibitormonomer2420-2981
99.82N3H;
Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydropyridinone inhibitormonomer2420-2981
99.82B42;
Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5h)monomer2420-2981
98.74SO4;5H;
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB655264monomer2420-2981
99.28699;
Novel Thiazolones as HCV NS5B Polymerase Inhibitors: Further Designs, Synthesis, SAR and X-ray Comp…monomer2422-2983
99.46VXR;
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
99.824MS;
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of stru…monomer2422-2983
99.46VR1;
Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitormonomer2420-2981
99.82DEY;
Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitormonomer2420-2981
99.821PD;
HCV NS5B allosteric inhibitor complexmonomer2422-2983
99.46RNA;
Crystal structure of hcv ns5b polymerase with a novel benzisothiazole inhibitormonomer2420-2981
99.82B34;
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
99.82N34;
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitormonomer2420-2981
99.82321;
Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitormonomer2420-2981
99.82B80;
Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitormonomer2420-2981
99.822PD;
HCV NS5B RNA-dependent RNA polymerase in complex with non-nucleoside inhibitor MK-8876monomer2422-2983
99.19VY;
Hepatitis C virus RNA-dependent RNA polymerase NS5B with NNI-2 inhibitormonomer2421-2981
100.0NN2;
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2981
100.0NI;SX3;
Hepatitis C Virus polymerase NS5B (BK) with fragment-based compoundsmonomer2421-2981
100.012R;
Crystal structure of HCV NS5b 1b with (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyrimi…monomer2421-2981
100.0B5P;GOL;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 14 (N-(4-{(E)-2-[3-ter…monomer2421-2981
100.028V;
Hepatitis C virus RNA-dependent RNA polymerase NS5B with NNI-1 inhibitormonomer2421-2981
100.0NN3;
Hepatitis C virus polymerase NS5B with RO inhibitor for SAR studiesmonomer2421-2981
100.0SL4;
Hepatitis C virus polymerase NS5B with saccharin inhibitormonomer2421-2981
100.0H5S;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 13 (N-{2-[3-tert-butyl…monomer2421-2981
100.0GOL;2AY;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 12 (N-{2-[3-tert-butyl…monomer2421-2981
100.028R;
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2981
100.0NI;SX5;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 4 (N-(4-{2-[3-tert-but…monomer2421-2981
100.0DMS;28Q;
Hepatitis C virus polymerase NS5B with thiazine inhibitor 2monomer2421-2981
100.0H59;
Hepatitis C Virus polymerase NS5B (BK) with fragment-based compoundsmonomer2421-2981
100.01EP;
Hepatitis C virus polymerase NS5B (BK 1-570) with HCV-796 inhibitormonomer2421-2981
100.079Z;
Hepatitis C virus polymerase NS5B (BK 1-570) with thiazine inhibitormonomer2421-2981
100.0T18;NI;
Hepatitis C Virus polymerase NS5B (BK) with fragment-based compoundsmonomer2421-2981
100.0ZN;1ER;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with Compound 48 (N-({(3S)-1-[6-tert-…monomer2421-2981
100.0DMS;28M;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with RG7109 (N-{4-[6-tert-butyl-5-met…monomer2421-2981
100.0ZN;28L;
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 2 (3-(3-tert-butyl-4-m…monomer2421-2981
100.0MG;DMS;28O;
HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide bioisosteresmonomer2422-2981
99.460S2;
HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide bioisosteresmonomer2422-2981
99.460S3;
CRYSTAL STRUCTURE OF THE RNA DIRECTED RNA POLYMERASE OF HEPATITIS C VIRUSmonomer2420-2975
100.0
Crystal structure of HCV NS5B RNA polymerase with a novel piperazine inhibitormonomer2420-2972
99.82JT1;
Crystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitormonomer2420-2963
99.81JTP;
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE FROM 1B GENOTYPE IN COMPLEX WITH A NON-NUCLE…monomer2420-2950
100MN;VGI;
Crystal Structure of Hepatitis C Virus NS5B Polymerase in Complex with Thienopyrrole-Based Finger-L…monomer2420-2950
100.0MN;VGC;
Crystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…monomer2420-2950
100.0MN;CMF;
Crystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…monomer2420-2950
100.0MN;POO;
Structure of MK-3281, a Potent Non-Nucleoside Finger-Loop Inhibitor, in complex with the Hepatitis …monomer2420-2950
100.0IB8;MN;
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2zku.1.Amonomer0.832420-2985
99.82